Journal article
Post-treatment surveillance of patients with lymphoma treated with curative intent
Seminars in oncology, Vol.30(3), pp.375-381
06/2003
DOI: 10.1016/S0093-7754(03)00096-4
PMID: 12870139
Abstract
Hodgkin’s lymphoma and aggressive non-Hodgkin’s lymphoma (NHL) are common, potentially curable cancers. Despite modern therapy, many patients will relapse. A number of relapsing patients may be cured with subsequent treatment, including high-dose chemotherapy. Risk of relapse after potentially curative therapy is greatest in the first 2 years, and post-treatment surveillance should be concentrated during this time. Most patients will present with symptoms or physical findings at relapse. Physicians and patients should be aware of common symptoms associated with relapse, and laboratory and radiological testing should be used to assess such concerns.
Details
- Title: Subtitle
- Post-treatment surveillance of patients with lymphoma treated with curative intent
- Creators
- James E Wooldridge - Department of Internal Medicine, Division of Hematology, Oncology, and Blood & Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USABrian K Link - Department of Internal Medicine, Division of Hematology, Oncology, and Blood & Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA
- Resource Type
- Journal article
- Publication Details
- Seminars in oncology, Vol.30(3), pp.375-381
- Publisher
- Elsevier Inc
- DOI
- 10.1016/S0093-7754(03)00096-4
- PMID
- 12870139
- ISSN
- 0093-7754
- eISSN
- 1532-8708
- Language
- English
- Date published
- 06/2003
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984094746902771
Metrics
9 Record Views